Tech Company Financing Transactions
RHYTHM Health Funding Round
MPM Capital, New Enterprise Associates and OrbiMed joined a $15 million capital raise for RHYTHM Health. This venture round was announced on 12/31/2015.
Transaction Overview
Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Boylston St. 11th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Overview
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Gottesdiener
Chief Financial Officer
Hunter Smith
Chief Medical Officer
Fred Fiedorek
Chief Scientific Officer
Lex Ploeg
VP - Bus. Development
Nithya Desikan
Browse more venture capital transactions:
Prev: 12/31/2015: SUN Behavioral Health venture capital transaction
Next: 12/31/2015: Andarta Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs